THE PATHOGENIC MECHANISMS OF DERANGED FUNCTIONAL ACTIVITY OF CELL MEMBRANES IN PATIENTS WITH DIABETES MELLITUS TYPE I AND PRIMARILY DETECTED DIABETES MELLITUS TYPE II

N. P Mikayelyan , V. V Potiyemkin , A. A Terentyev , I. O Kulayeva , Ye. Yu Frantzeva

Russian Medicine ›› 2012, Vol. 18 ›› Issue (4) : 20 -22.

PDF
Russian Medicine ›› 2012, Vol. 18 ›› Issue (4) : 20 -22. DOI: 10.17816/rmj37994
Articles
research-article

THE PATHOGENIC MECHANISMS OF DERANGED FUNCTIONAL ACTIVITY OF CELL MEMBRANES IN PATIENTS WITH DIABETES MELLITUS TYPE I AND PRIMARILY DETECTED DIABETES MELLITUS TYPE II

Author information +
History +
PDF

Abstract

In patients with diabetes mellitus type I and primarily detected diabetes mellitus type II the metabolic deficiency inherently occurs of aerobic synthesis of ATP as a result of of glycolytic processes activation, lactate concentration increase and lipid peroxidation development. The misbalance in the lipid peroxidation-antioxidant defense system against the background of dyshyperlipemia and lactate concentration increase testifies the development of oxidative stress, especially marked under diabetes mellitus type II. The degree decrease of glucose utilization by erythrocytes and inhibition of activity of K+, Na +-ATPase indicate the desensitivity of cells to insulin. The alterations of under study indicators depend on diabetes type and duration of disease course. The findings reflect the manifestation of common adaptive mechanisms in disease development which promote the adaptation to the negative impact of active forms of oxygen.

Keywords

insulin receptor / glucose utilization by cells / enzyme-antioxidant / glucose-insulin homeostasis / metabolic status

Cite this article

Download citation ▾
N. P Mikayelyan, V. V Potiyemkin, A. A Terentyev, I. O Kulayeva, Ye. Yu Frantzeva. THE PATHOGENIC MECHANISMS OF DERANGED FUNCTIONAL ACTIVITY OF CELL MEMBRANES IN PATIENTS WITH DIABETES MELLITUS TYPE I AND PRIMARILY DETECTED DIABETES MELLITUS TYPE II. Russian Medicine, 2012, 18(4): 20-22 DOI:10.17816/rmj37994

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Балаболкин М. И., Клебанова Е. М. // Тер. арх. — 2003. — № 1. — C. 72—77.

[2]

Зенков Н. К., Панкин В. З., Менщикова Е. Б. Окислительный стресс. Биохимический и патофизиологический аспекты. — М.: Майк "Наука/Интерпериодика", 2001.

[3]

Макаренко Е. В. // Лаб. дело. — 1986. — № 3. — C. 14—17.

[4]

Микаелян Н. П., Князев Ю. А., Максина А. Г., Петрухин В. А. // Пробл. эндокринол. — 1994. — Т. 40, № 4. — C. 4—7.

[5]

Микаелян Н. П., Князев Ю. А., Петрухин В. А., Микаелян А. В. // Сахарный диабет. — 2006. — № 1. — C. 15—17.

[6]

Нелаева А. А., Трошина И. А. // Сахарный диабет. — 1999. — № 3. — C. 25—29.

[7]

Смирнова О. М., Никонова Т. В., Дедов И. И. Свободно-радикальное окисление и антиоксидантная защита при сахарном диабете: Пособие для врачей. — М., 2003.

[8]

Boden G., Shulman G. // Eur. J. Clin. Invest. — 2002. — Vol. 32 (suppl 3). — P. 14—23.

[9]

Brownlee M. // Nature. — 2001. — Vol. 414. — P. 813—820.

[10]

Evans J. L. et al. // Endocr. Rev. — 2002. — Vol. 23. — P. 599—622.

[11]

Mc Garry J. D., Dobbins R. L. // Diabetologia. — 1999. — Vol. 42. — P. 128—138.

[12]

Mercuri F., Quagliaro L., Ceriello A. // Diabetes Tеchnol. Ther. — 2000. — Vol. 10, N 2—3. — P. 157—167.

[13]

Munday R., Winterboume C. C. // Biochem. Pharmacol. — 1989. — Vol. 38. — P. 4349—4352.

[14]

Osacawa I., Matsushita S. // Lipids. — 1980. — Vol. 15, N 3. — P. 137—140.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

130

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/